ACON
Aclarion IncKey Statistics
About Aclarion Inc
Aclarion Inc (ACON) is a pioneering healthcare technology company that specializes in non-invasive diagnostics, focusing on musculoskeletal conditions through innovative imaging and advanced data analytics. By harnessing machine learning, Aclarion provides healthcare professionals with actionable insights that enhance clinical outcomes while optimizing costs within treatment pathways. Positioned at the vanguard of the digital health transformation, Aclarion is poised to meet the increasing demand for effective diagnostic solutions, significantly enhancing the standard of patient care in an evolving healthcare landscape. Its commitment to improving patient management establishes Aclarion as a key player in the future of healthcare delivery.
Fundamentals
| Revenue (TTM) | 77,880 |
| Gross Profit (TTM) | 15,070 |
| EBITDA | $-8.31M |
| Operating Margin | -14129.00% |
| Return on Equity | -45.40% |
| Return on Assets | -28.80% |
| Revenue/Share (TTM) | $0.08 |
| Book Value | $8.04 |
| Price-to-Book | 0.40 |
| Price-to-Sales (TTM) | 101.49 |
| EV/Revenue | 96.41 |
| EV/EBITDA | -0.56 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 11.30% |
| Shares Outstanding | $2.46M |
| Float | $2.21M |
| % Insiders | 10.56% |
| % Institutions | 4.35% |
Historical Volatility
Volatility is currently contracting